Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S, Efferth T.
Int J Mol Med. 2008 Oct;22(4):411-9.
PMID:18813846
Treatment options for second-stage gambiense human African trypanosomiasis.
Eperon G, Balasegaram M, Potet J, Mowbray C, Valverde O, Chappuis F.
Target product profile: Trypanosoma brucei gambiense test for low-prevalence settings.
Priotto G, Franco JR, Lejon V, Büscher P, Matovu E, Ndung'u J, Biéler S, Mumba D, Van Reet N, Verlé P, Jamonneau V, Simarro PP, Ebeja AK, Sankara D, Dagne DA.
Bull World Health Organ. 2023 Aug 1;101(8):541-545. doi: 10.2471/BLT.23.290176. Epub 2023 Jun 26.
PMID:37529025
Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?
Informal Expert Group on Gambiense HAT Reservoirs; Büscher P, Bart JM, Boelaert M, Bucheton B, Cecchi G, Chitnis N, Courtin D, Figueiredo LM, Franco JR, Grébaut P, Hasker E, Ilboudo H, Jamonneau V, Koffi M, Lejon V, MacLeod A, Masumu J, Matovu E, Mattioli R, Noyes H, Picado A, Rock KS, Rotureau B, Simo G, Thévenon S, Trindade S, Truc P, Van Reet N.
Trends Parasitol. 2018 Mar;34(3):197-207. doi: 10.1016/j.pt.2017.11.008. Epub 2018 Jan 23.